TRAF2 Must Bind to Cellular Inhibitors of Apoptosis for Tumor Necrosis Factor (TNF) to Efficiently Activate NF-κB and to Prevent TNF-induced Apoptosis

Overview of attention for article published in Journal of Biological Chemistry, December 2009

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (74th percentile)
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

patent: 6 patents

Readers on

mendeley: 178 Mendeley

So far, Altmetric has seen 6 patents that reference this research output.

Pyrido[2,3-b][1,4]oxazines or tetrahydropyrido[2,3-b][1,4]oxazepines as IAP antagonists

Grant US-12583866-B2

United States of America

24 Mar 2026

Substituted benzimidazoles as inhibitors of transforming growth factor-β kinase

Grant US-11767298-B2

United States of America

26 Sep 2023

PYRIDO[2,3-B] [1,4] OXAZINES OR TETRAHYDROPYRIDO[2,3-B][1,4] OXAZEPINES AS IAP ANTAGONISTS

Application WO-2021244608-A1

World Intellectual Property Organisation (WIPO)

09 Dec 2021

Substituted benzimidazoles as inhibitors of transforming growth factor-β kinase

Grant US-10927083-B2

United States of America

23 Feb 2021

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 2 additional patents.